If we dont address that, the physical changes often dont last. She emphasizes that obesity is recognized as a chronic medical condition not a character flaw and that compassionate, evidence-based treatment changes outcomes
While not a health risk, this skin laxity can become a cosmetic concern that impacts confidence and self-imagekey reasons why many individuals turn to these medications in the first place
To understand where this compound fits in the broader history of these molecules, you can read our comprehensive GLP-1 class overview
Week-by-Week Breakdown Week 1: The Beginning What youll experience: Possibly nothing at all
The benefits of GLP-1 to treat both type 2 diabetes and obesity are game-changing, reducing the risk of common side effects as well as of complications associated to both conditions.
The most practical approach for many protocols involves starting with a 5mg vial for the early escalation phases and switching to a 10mg vial once weekly doses are higher